ArticleBMJ open2022

Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin - study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.

Julian Singer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.